Am. J. Respir. Cell Mol. Biol.,
Volume 25, Number 4, October, 2001 447-456
Fetal Alveolar Epithelial Cells Contain [D-Ala2]-Deltorphin
I-like Immunoreactivity
- and µ-Opiate Receptors Mediate Opposite Effects in Developing Lung
Mary E.
Sunday,
Kathleen J.
Haley,
Rodica L.
Emanuel,
John S.
Torday,
Nithiananthan
Asokananthan,
Kristan A.
Sikorski,
Ikuo
Tooyama,
Hiroshi
Kimura,
Tindaro
Renda,
and
Vittorio
Erspamer
Departments of Pathology, Children's Hospital, Brigham & Women's Hospital, and Harvard Medical School; Department of Medicine,
Brigham & Women's Hospital and Harvard Medical School; Department of Medicine, Children's Hospital and Harvard Medical School,
Boston, Massachusetts; Department of Pediatrics, University of California at Los Angeles, Los Angeles, California;
Department of Anatomy, Shiga University of Medical Science, Otsu, Shiga, Japan; and Institute of Human Anatomy and
Emeritus of Medical Pharmacology, University La Sapienza, Rome, Italy
Opiate-like peptides can regulate many cellular functions. We
now map [D-Ala2]deltorphin I (DADTI)-like immunoreactivity
(DADTI-LI) in developing mouse lung and analyze potential
functional roles. Most DADTI-LI-positive cells were alveolar cells
negative for prosurfactant protein (proSP)-C immunoreactivity. Peak numbers of DADTI-LI-positive cells occurred on embryonic Day 18, decreasing postnatally. To analyze developmental effects of DADTI, e17-18 lung explants were treated
with [D-Ala2]deltorphin II (DADTII, soluble DADTI analogue,
-receptor-specific) versus dermorphin (µ-receptor-specific).
Type II pneumocyte differentiation, assessed by [3H]choline incorporation into saturated phosphatidylcholine and proSP-C
immunostaining, was inhibited by DADTII but stimulated by
dermorphin. Cell proliferation, measured as [3H]-thymidine incorporation and proliferating cell nuclear antigen immunostaining, was stimulated by DADTII and inhibited by dermorphin. All effects were dose-dependent. DADTII-inhibited choline incorporation was reversed by the
-blocker, naltrindole. Unexpectedly, DADTII-stimulated thymidine incorporation was augmented by naltrindole and reversed by naloxone (µ-blocker).
Although dermorphin-stimulated choline incorporation was appropriately blocked by binaltorphimine, dermorphin-inhibited thymidine incorporation was reversed by
,
-, or µ-blockers. The
- and µ-receptor messenger RNAs occurred pre- and
postnatally, whereas
-receptor transcripts occurred mainly
prenatally. All three receptor proteins were present in epithelial and mesenchymal cells in e18 lung. Thus, DADTI-LI from
proSP-C-immunonegative alveolar cells could regulate development via both direct and indirect effects involving multiple
opiate receptors.
Abbreviations: [D-Ala2]deltorphin I, DADTI; DADTI-like immunoreactivity, DADTI-LI; [D-Ala2]deltorphin II, DADTII; saturated phosphatidylcholine, DSPC; embryonic Day, e; messenger RNA, mRNA; postnatal
Day, P; proliferating cell nuclear antigen, PCNA; prosurfactant protein,
proSP; reverse-transcribed polymerase chain reaction, RT-PCR; surfactant protein, SP; tyramide system amplification, TSA.